Mersana Therapeutics Inc
NASDAQ:MRSN

Watchlist Manager
Mersana Therapeutics Inc Logo
Mersana Therapeutics Inc
NASDAQ:MRSN
Watchlist
Price: 27.775 USD 1.11% Market Closed
Market Cap: 138.9m USD

Wall Street
Price Targets

MRSN Price Targets Summary
Mersana Therapeutics Inc

Wall Street analysts forecast MRSN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRSN is 33.864 USD with a low forecast of 27.523 USD and a high forecast of 52.5 USD.

Lowest
Price Target
27.523 USD
1% Downside
Average
Price Target
33.864 USD
22% Upside
Highest
Price Target
52.5 USD
89% Upside
Mersana Therapeutics Inc Competitors:
Price Targets
BMRN
Biomarin Pharmaceutical Inc
74% Upside
ONCO
Oncopeptides AB
1% Downside
688235
Beigene Ltd
32% Upside
CNTB
Connect Biopharma Holdings Ltd
236% Upside
688331
RemeGen Co Ltd
3% Downside
MIRM
Mirum Pharmaceuticals Inc
31% Upside
VYGR
Voyager Therapeutics Inc
257% Upside
4BB
4Basebio PLC
143% Upside

Revenue
Forecast

Revenue Estimate
Mersana Therapeutics Inc

For the last 8 years the compound annual growth rate for Mersana Therapeutics Inc's revenue is 6%. The projected CAGR for the next 3 years is -36%.

6%
Past Growth
-36%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mersana Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Mersana Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRSN's stock price target?
Price Target
33.864 USD

According to Wall Street analysts, the average 1-year price target for MRSN is 33.864 USD with a low forecast of 27.523 USD and a high forecast of 52.5 USD.

What is Mersana Therapeutics Inc's Revenue forecast?
Projected CAGR
-36%

For the last 8 years the compound annual growth rate for Mersana Therapeutics Inc's revenue is 6%. The projected CAGR for the next 3 years is -36%.

Back to Top